Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2011 1
2012 1
2017 1
2018 3
2019 4
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Restructuring of the 'Macaronesia' biogeographic unit: A marine multi-taxon biogeographical approach.
Freitas R, Romeiras M, Silva L, Cordeiro R, Madeira P, González JA, Wirtz P, Falcón JM, Brito A, Floeter SR, Afonso P, Porteiro F, Viera-Rodríguez MA, Neto AI, Haroun R, Farminhão JNM, Rebelo AC, Baptista L, Melo CS, Martínez A, Núñez J, Berning B, Johnson ME, Ávila SP. Freitas R, et al. Among authors: wirtz p. Sci Rep. 2019 Nov 5;9(1):15792. doi: 10.1038/s41598-019-51786-6. Sci Rep. 2019. PMID: 31690834 Free PMC article.
Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15.
Ochoa MC, Minute L, López A, Pérez-Ruiz E, Gomar C, Vasquez M, Inoges S, Etxeberria I, Rodriguez I, Garasa S, Mayer JA, Wirtz P, Melero I, Berraondo P. Ochoa MC, et al. Among authors: wirtz p. Oncoimmunology. 2017 Nov 13;7(2):e1393597. doi: 10.1080/2162402X.2017.1393597. eCollection 2018. Oncoimmunology. 2017. PMID: 29308327 Free PMC article.
Preclinical Development of U3-1784, a Novel FGFR4 Antibody Against Cancer, and Avoidance of Its On-target Toxicity.
Bartz R, Fukuchi K, Ohtsuka T, Lange T, Gruner K, Watanabe I, Hayashi S, Oda Y, Kawaida R, Komori H, Kashimoto Y, Wirtz P, Mayer JA, Redondo-Müller M, Saito S, Takahashi M, Hanzawa H, Imai E, Martinez A, Hanai M, Häussinger D, Chapman RW, Agatsuma T, Bange J, Abraham R. Bartz R, et al. Among authors: wirtz p. Mol Cancer Ther. 2019 Oct;18(10):1832-1843. doi: 10.1158/1535-7163.MCT-18-0048. Epub 2019 Jul 26. Mol Cancer Ther. 2019. PMID: 31350344
11 results